When DAB working solution was added to the DGC-labeled AD brain sections, the POD-catalyzed brown product was deposited in situ, and its brown intensity was also proportional to the expression of CTGF, which could distinguish the AD mouse brain from the WT mouse brain (Fig. 4b and Fig. S4c). Here, CCN2 is linked to Alzheimer disease.